Home » ALZA CORPORATION RECEIVES FDA APPROVAL FOR IONSYS
ALZA CORPORATION RECEIVES FDA APPROVAL FOR IONSYS
May 25, 2006
The US Food and Drug Administration (FDA) has approved IONSYS(TM) (fentanyl iontophoretic transdermal system), the first needle-free, patient-activated analgesic system. IONSYS is indicated for the short-term management of acute post-operative pain in adult patients requiring opioid analgesia during hospitalization.
PR Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct